Jiang Yang

Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.

Purvalanol A induces apoptosis and reverses cisplatin resistance in ovarian cancer.

Journal: Anti-cancer drugs

Published: August 10, 2022

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.

A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.

Journal: Frontiers in immunology

Published: May 13, 2022

Targeting purine metabolism in ovarian cancer.

Targeting purine metabolism in ovarian cancer.

Journal: Journal of ovarian research

Published: May 10, 2022

Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer.

Tumor Immune Microenvironment Related Gene-Based Model to Predict Prognosis and Response to Compounds in Ovarian Cancer.

Journal: Frontiers in oncology

Published: November 02, 2021

Robotic and laparoscopic sacrocolpopexy for pelvic organ prolapse: a systematic review and meta-analysis.

Robotic and laparoscopic sacrocolpopexy for pelvic organ prolapse: a systematic review and meta-analysis.

Journal: Annals of translational medicine

Published: April 14, 2021

A New Modified Hysteroscopic-Laparoscopic Surgery for Cesarean Scar Pregnancy of Stable Type III.

A New Modified Hysteroscopic-Laparoscopic Surgery for Cesarean Scar Pregnancy of Stable Type III.

Journal: International journal of general medicine

Published: February 27, 2021

Gynecological prevention and control model based on ward rearrangement and zoning management in pandemic period of COVID-19.

Gynecological prevention and control model based on ward rearrangement and zoning management in pandemic period of COVID-19.

Journal: Panminerva medica

Published: May 17, 2020

Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic.

Treatment and Prevention Strategies for Patients with Gynecological Malignancies During the COVID-19 Pandemic.

Journal: Risk management and healthcare policy

Published: May 07, 2020

Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.

Role of Jagged1/STAT3 signalling in platinum-resistant ovarian cancer.

Journal: Journal of cellular and molecular medicine

Published: October 30, 2018

Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.

Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.

Journal: Oncology reports

Published: June 04, 2018

[Expression of Concern] Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.

[Expression of Concern] Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.

Journal: Oncology reports

Published: June 04, 2018

Therapeutic Effects of Punicalagin Against Ovarian Carcinoma Cells in Association With β-Catenin Signaling Inhibition.

Therapeutic Effects of Punicalagin Against Ovarian Carcinoma Cells in Association With β-Catenin Signaling Inhibition.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 20, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026